NasdaqCM - Nasdaq Real Time Price USD
MetaVia Inc. (MTVA)
0.6869
+0.0151
+(2.25%)
At close: June 4 at 4:00:01 PM EDT
0.6751
-0.01
(-1.72%)
After hours: June 4 at 7:02:34 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -1.12 | -0.73 | -0.74 | -0.65 |
EPS Actual | -1.85 | -0.55 | -0.32 | -0.36 |
Difference | -0.73 | 0.18 | 0.42 | 0.29 |
Surprise % | -64.69% | 24.66% | 56.76% | 44.62% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MTVA | -- | -- | -- | -- |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
Maintains | Maxim Group: Buy to Buy | 5/19/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/16/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
Initiated | HC Wainwright & Co.: Buy | 12/30/2024 |
Related Tickers
IPHA Innate Pharma S.A.
2.1400
+0.47%
DRMA Dermata Therapeutics, Inc.
0.7080
+0.53%
GLYC GlycoMimetics, Inc.
0.2100
+0.48%
BOLT Bolt Biotherapeutics, Inc.
0.3238
+6.69%
PALI Palisade Bio, Inc.
0.7175
-2.38%
ZURA Zura Bio Limited
1.1800
+9.77%
ARTL Artelo Biosciences, Inc.
1.1006
+2.86%
KANT Kineta, Inc.
0.2159
-4.21%
CMND Clearmind Medicine Inc.
0.9041
-4.18%
NXTC NextCure, Inc.
0.4731
-0.13%